|
1
|
Chen BY, Wang X, Chen LW and Luo ZJ:
Molecular targeting regulation of proliferation and differentiation
of the bone marrow-derived mesenchymal stem cells or mesenchymal
stromal cells. Curr Drug Targets. 13:561–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Satija NK, Gurudutta GU, Sharma S, et al:
Mesenchymal stem cells: molecular targets for tissue engineering.
Stem Cells Dev. 16:7–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ling L, Nurcombe V and Cool SM: Wnt
signaling controls the fate of mesenchymal stem cells. Gene.
433:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Boer J, Wang HJ and Van Blitterswijk C:
Effects of Wnt signaling on proliferation and differentiation of
human mesenchymal stem cells. Tissue Eng. 10:393–401.
2004.PubMed/NCBI
|
|
5
|
Shtutman M, Zhurinsky J, Oren M, Levina E
and Ben-Ze’ev A: PML is a target gene of β-catenin and
plakoglobin, and coactivates β-catenin-mediated transcription.
Cancer Res. 62:5947–5954. 2002.
|
|
6
|
Scaglioni PP, Yung TM, Cai LF, et al: A
CK2-dependent mechanism for degradation of the PML tumor
suppressor. Cell. 126:269–283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Regad T, Bellodi C, Nicotera P and
Salomoni P: The tumor-suppressor Pml regulates cell fate in the
developing neocortex. Nat Neurosci. 12:132–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salomoni P, Dvorkina M and Michod D: Role
of the promyelocytic leukaemia protein in cell death regulation.
Cell Death Dis. 3:e2472012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ito K, Bernardi R, Morotti A, et al: PML
targeting eradicates quiescent leukaemia-initiating cells. Nature.
453:1072–1078. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meuleman N, Tondreau T, Delforge A, et al:
Human marrow mesenchymal stem cell culture: serum-free medium
allows better expansion than classical α-MEM medium. Eur J
Haematol. 76:309–316. 2006.PubMed/NCBI
|
|
11
|
Liu L, Yu Q, Lin J, et al:
Hypoxia-inducible factor-1α is essential for hypoxia-induced
mesenchymal stem cell mobilization into the peripheral blood. Stem
Cells Dev. 20:1961–1971. 2011.
|
|
12
|
Zhang L, Zheng W, Wang Y and Huang H:
Human bone marrow mesenchymal stem cells support the derivation and
propagation of human induced pluripotent stem cells in culture.
Cell Reprogram. 15:216–223. 2013.PubMed/NCBI
|
|
13
|
Gay IC, Chen S and MacDougall M: Isolation
and characterization of multipotent human periodontal ligament stem
cells. Orthod Craniofac Res. 10:149–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferbeyre G, de Stanchina E, Querido E,
Baptiste N, Prives C and Lowe SW: PML is induced by oncogenic
ras and promotes premature senescence. Genes Dev.
14:2015–2027. 2000.
|
|
15
|
Salomoni P, Ferguson BJ, Wyllie AH and
Rich T: New insights into the role of PML in tumour suppression.
Cell Res. 18:622–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang ZG, Ruggero D, Ronchetti S, et al:
PML is essential for multiple apoptotic pathways. Nat Genet.
20:266–272. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Lu Y, Huang W, et al: In vitro
effect of adenovirus-mediated human Gamma Interferon gene transfer
into human mesenchymal stem cells for chronic myelogenous leukemia.
Hematol Oncol. 24:151–158. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lallemand-Breitenbach V and de Thé H: PML
nuclear bodies. Cold Spring Harb Perspect Biol. 2:a0006612010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi Y, Lallemand-Breitenbach V, Zhu
J and de Thé H: PML nuclear bodies and apoptosis. Oncogene.
23:2819–2824. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Conget PA and Minguell JJ: Phenotypical
and functional properties of human bone marrow mesenchymal
progenitor cells. J Cell Physiol. 181:67–73. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
George J, Kuboki Y and Miyata T:
Differentiation of mesenchymal stem cells into osteoblasts on
honeycomb collagen scaffolds. Biotechnol Bioeng. 95:404–411. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ogawa R, Mizuno H, Watanabe A, Migita M,
Shimada T and Hyakusoku H: Osteogenic and chondrogenic
differentiation by adipose-derived stem cells harvested from GFP
transgenic mice. Biochem Biophys Res Commun. 313:871–877. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Keselowsky BG, Collard DM and García AJ:
Integrin binding specificity regulates biomaterial surface
chemistry effects on cell differentiation. Proc Natl Acad Sci USA.
102:5953–5957. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ilmer M, Karow M, Geissler C, Jochum M and
Neth P: Human osteoblast-derived factors induce early osteogenic
markers in human mesenchymal stem cells. Tissue Eng Part A.
15:2397–2409. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimizu E, Matsuda-Honjyo Y, Samoto H, et
al: Static magnetic fields-induced bone sialoprotein (BSP)
expression is mediated through FGF2 response element and
pituitary-specific transcription factor-1 motif. J Cell Biochem.
91:1183–1196. 2004. View Article : Google Scholar
|
|
27
|
Zhang X, Odom DT, Koo SH, et al:
Genome-wide analysis of cAMP-response element binding protein
occupancy, phosphorylation, and target gene activation in human
tissues. Proc Natl Acad Sci USA. 102:4459–4464. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doucas V: The promyelocytic (PML) nuclear
compartment and transcription control. Biochem Pharmacol.
60:1197–1201. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marie PJ: Fibroblast growth factor
signaling controlling bone formation: an update. Gene. 498:1–4.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ryu E, Hong S, Kang J, et al:
Identification of senescence-associated genes in human bone marrow
mesenchymal stem cells. Biochem Biophys Res Commun. 371:431–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Coutu DL, François M and Galipeau J:
Inhibition of cellular senescence by developmentally regulated FGF
receptors in mesenchymal stem cells. Blood. 117:6801–6812. 2011.
View Article : Google Scholar : PubMed/NCBI
|
